Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT06841458
Eligibility Criteria:
Inclusion Criteria:
* Written consent for LOPD compliance.
* Written informed consent for study DC.506.36.117.
* Gender: Male.
* Age: Between 18 and 45 years.
* Diagnosis of alopecia with low hair density, classified as mild to moderate (stages II, III, and IV on the Hamilton-Norwood scale).
Willingness to have a 1-2 cm² area shaved throughout the study period.
* Last participation in a clinical study on hair health must have ended at least six months before the start of this study.
* 30-day washout period without specific hair treatments (using a neutral shampoo).
* No use of any other topical or oral hair treatments in the target area during the study period; if necessary, consultation with the principal investigator is required to evaluate continued study participation.
Exclusion Criteria:
* Individuals with gastrointestinal diseases (e.g., diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.).
* Individuals with other physiological disorders (e.g., diabetes, hypertension, dyslipidemia) and/or gallstones.
* Individuals undergoing medical treatment in the weeks prior to the study that may interfere with study assessments (as determined by the investigator), particularly those who are currently taking or have taken 5α-reductase inhibitors (Finasteride, Dutasteride, Minoxidil, etc.) within the last three months.
Individuals who have undergone hair restoration treatments at any point in their lives, including hair transplants, mesotherapy, or platelet-rich plasma (PRP) therapy.
* Individuals following an atypical diet or planning to change their dietary routine during the study period.
* Individuals enrolled in another clinical study with similar characteristics (as determined by the investigator) during the study period.
* Individuals who are unable to fully understand the informed consent document or adhere to the study protocol.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT06841458
Study Brief:
Protocol Section:
NCT06841458